CareDx, Inc. (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
17.95
-0.80 (-4.27%)
Mar 6, 2026, 11:36 AM EST - Market open
CareDx Employees
As of December 31, 2025, CareDx had 765 total employees, including 761 full-time and 4 part-time employees. The number of employees increased by 115 or 17.69% compared to the previous year.
Employees
765
Change (1Y)
115
Growth (1Y)
17.69%
Revenue / Employee
$496,477
Profits / Employee
-$27,914
Market Cap
919.33M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Neogen | 2,974 |
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| GRAIL | 1,000 |
| Twist Bioscience | 979 |
CDNA News
- 19 hours ago - CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx's Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets - Business Wire
- 6 days ago - CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 9 days ago - CareDx, Inc. (CDNA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer - Business Wire
- 9 days ago - CareDx Announces Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 16 days ago - CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference - Business Wire
- 18 days ago - Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells - Seeking Alpha
- 21 days ago - CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy Transcript - Seeking Alpha